Introduction
Antibodies of the immunoglobulin E (IgE) isotype are well-described, key components of the defense against parasites and also of type 1-hypersensitivity reactions. The mechanisms behind the development of diversity in IgE antibody repertoires, however, are a matter of substantial debate. The classical view of development of hypermutated antibodies is that selection of B cells producing such antibodies occurs in germinal centers. To ensure development towards a high affinity antibody this process is believed to favor replacement mutations targeting the complementarity determining regions (CDR) rather than silent mutations. In contrast, replacement mutations are counter-selected in the framework regions (FR), as they are likely to be accompanied by unacceptable structural effects on the folded protein. The end product of this antigen selection process should be a pool of B cells carrying genes encoding antigen-specific, high-affinity antibodies. However, in the case of IgE-repertoire develop-ment, alternative mechanisms have been proposed, not necessarily involving selection by antigen [1] . For instance, extensive polyclonal expansion of B cells producing IgE has been suggested to be a major contributor to the establishment of such antibodies [1, 2] . Microbial toxins might act as superantigens, exhibiting excessive polyclonal mitogenic activity on B cell populations. Such repertoires may be dominated by sequences that carry a lower than expected number of substitutions in the CDR as there will be no selective advantage in creating an optimal binding site towards a conventional antigen. Indeed, some [2] [3] [4] [5] but not all [6] studies have indicated evidence of mutations in IgE not compatible with selection by antigens.
What then is the basis for the differences between different studies of the involvement of selection in the shaping of IgE repertoires? Firstly, the studies have assessed IgE in different clinical conditions and it is not unreasonable to expect that IgE develop in different ways in different diseases. Secondly, the analytical approach is a source of error. Identification of antigen-directed selection in antibody evolution is problematic for a number of reasons including, but not limited to, high background of neutral mutations, different codon usage in different parts of antibody sequences and differences in the mutagen ability of different codons [7] [8] [9] [10] [11] . Furthermore, unequivocal assignment of germline gene origin is difficult as there is generally no knowledge of the germline gene repertoire that generated the IgE repertoires. Consequently misassignment has probably occurred in several cases, adding irrelevant noise to the data set.
To minimize the influence of methodological differences we have now re-assessed the pattern of mutations in several IgE-encoding gene populations using a single, extensively validated methodology [10] [11] [12] to define whether or not it is possible to pin-point antigen selection as a major driving force shaping the development of IgE repertoires as they are described in today's literature.
Materials and Methods

Study Material
Antibody heavy chain variable domain-encoding sequences ( table 1 ; online suppl. table 1; for all online suppl. material, see www.karger.com/doi/10.1159/000345421) were derived from IgEproducing cells found in peripheral blood of patients diagnosed with allergic rhinitis [13, 14] and in sinus mucosa of patients diagnosed with chronic rhinosinusitis or non-allergic fungal eosinophilic sinusitis [15] , the latter being a condition devoid of systemic allergy but with signs of local reactions similar to allergic inflammation. We also included sequences encoding IgE derived In addition, several different allelic variants of these germline genes were used in some repertoires.
2 Test was performed as described by Uduman et al. [12] . Positive and negative p values suggest positive and negative selection, respectively. Repertoires showing significant evidence for selection are shaded in grey.
from children with allergic asthma [6] and parasitized subjects [5] in this study. In addition, two repertoires of antibodies, likely mostly IgG, specific for tetanus toxoid and vaccinia virus of recently boosted individuals were included for comparison [16, 17] .
Analysis
To avoid repeated analysis of frequently occurring rearrangements, only one randomly picked sequence of the different clonotypes [a clonotype is defined as described by the authors or as a set of clones with an origin in a given rearrangement (with an origin in a common IGHV gene and a nucleotide identity within the heavy chain CDR3 of 1 80%) that has occurred in a single individual] was used in the study. To be included, a sequence from each clonotype must also be accessible from GenBank. The sequence must furthermore be complete across the investigated sequence, must not show evidence (as assessed by the V-QUEST algorithm [18] ) of mutations involving insertions or deletions, and must not contain unspecified bases. The IGHV gene/allele that had been used in the process that generated a rearranged heavy-chain encoding sequence was defined using the IMGT/V-QUEST online tool [18] . As PCR had been used to amplify sequences, bases comprising the first codons were not included in the analysis in order to avoid an influence of primer design on the assignment of germline gene origin and mutation. Consequently, codons 1-8 were always excluded and, in the case of sequences described by Kerzel et al. [6] , codons 1-26 were excluded. All these gene populations represent diverse sets of sequences in terms of V gene subgroup and gene usage ( table 1 ). All sets also carry high frequencies of mutations at the nucleotide level ( table 1 ) .
The analysis of selection was performed using the extensively validated focused binomial test (http://clip.med.yale.edu/sel/) as described by Hershberg et al. [11] and as modified by Uduman et al. [12] . We used the default setting of the online tool, i.e. CDR were defined as codons 27-38 and 56-65 in accordance with the unique IMGT CDR definition rules and the IMGT numbering system [19] . These residues create a surface directed towards an antigen sitting in a binding site and avoid analysis of residues in the C'' ␤ -strand of the folded heavy chain variable domain as included in the Kabat definition of the second heavy chain CDR. Codons beyond residue 104 were not included in the analysis to eliminate confounding effects caused by sequence alterations associated with VDJ rearrangement process, i.e. modifications that are unrelated to the somatic hypermutation and the selection process. The Benjamini-Hochberg false discovery method was employed, using an on-line tool (http://sdmproject.com/ utilities/?show = FDR) to correct for the fact that multiple statistical tests were performed.
Results and Discussion
In agreement with prior studies of mutated immunoglobulin sequences [5, 7] , the vast majority of sequences did not show statistically significant evidence of positive or negative selection on their own (data not shown). All populations showed strong negative selection against mutations in immunoglobulin FR ( table 1 ), in agreement with expectations (assuming that many mutations in FR will detrimentally influence the stability of the V domains) and past experience [10] . Furthermore, there was little evidence of positive selection in the CDR of IgEencoding sequence populations. Only IgE derived from parasitized individuals [5] showed statistically significant selection in CDR, in this case negative selection. This is in agreement with past studies of this population of sequences that showed less evidence of antigen selection as compared to IgG [5] . The study by Kerzel et al. [6] , which involved sequencing of more than 1,000 IgE-encoding genes from 13 lymphocyte donors, has previously reported evidence of antigen selection in IgE. That repertoire, however, did not show evidence of positive selection as assessed using the focused binomial test. Importantly though, the tetanus toxoid-specific and the vaccinia virus-specific antibody populations also did not show evidence of positive selection in CDR using the focused binomial test system. This finding suggests that an extensively validated analytical approach like the one employed in this study cannot with ease detect positive selection in human antibody populations highly suspected to have undergone positive selection. This points to the limitation of the approach itself. It has previously even been suggested that none of the frequently used tests, approaches such as the binomial test [8] , the multinomial test [20] or the focused binomial test [11] , are able to detect selection by antigen in the CDR of immunoglobulinencoding transcripts [10] . This highlights the complexity of designing such algorithms with high enough specificity without reducing sensitivity to levels where selection is very difficult to detect. The lack of selection was not accompanied by a low level of mutation in the sequences used for analysis as the frequency of mutation was 5.6-8.4% ( table 1 ) . Thus, sample sizes like those used in this study, a size common to most studies of IgE-encoding gene sequences, are likely insufficient to establish evidence of positive selection in CDR using those tests available today.
The failure to detect evidence for positive selection in sets of antibody-encoding genes of sizes common to many studies of IgE repertoires suggests that new approaches need to be taken to address this issue. One has to realize that it is by no means certain that antigen selection translates into a mathematically detectable enhancement of substitutions in CDR. Indeed, many affinity-enhancing mutations do not reside in CDR [21] , a fact that confounds this analytical approach. It has also been argued that false-positive results are frequent, in particular when not applying an analytical strategy based on a focused binomial methodology and, even more damaging, that one should not even expect to find mathematically detectable signs of selection in the CDR of antigen-binding sites of antibodies [10] .
If we ever are going to be able to detect subtle increases in substitution in CDR as a consequence of antigen selection, a problem is that even rather extensive conventional sequencing efforts (exemplified by Kerzel et al. [6] ) generate a relatively small number of independent clones due to the oligoclonal nature of IgE repertoires [13] . It is expected that larger, carefully controlled studies to clarify the existence, or not, of positive and negative selective pressure during the development of the different human IgE repertoires will be required to resolve this matter. It is anticipated that high throughput sequencing of genes derived from large numbers of donors may aid in this endeavor. Firstly, such methodology provides larger data sets that may be required to resolve this matter with statistical significance. Secondly, the methodology can be used to deduce the germline repertoire of each individual [22] , thereby facilitating correct germline gene assignments eliminating background noise in the data set. It is anticipated that such efforts may eventually permit us to address this matter.
Ultimately the resolution of the matter of whether or not selection for higher affinity occurs in human IgE may have to await a very laborious analysis of mutated, allergen-specific IgE clones in comparison to their unmutated germline counterparts. Current technology has, as far as we are aware, not been able to identify gene sequences encoding native combinations of heavy and light chain variable domains of IgE with known allergen specificity, for instance through sorting of cells of the B cell lineage by flow cytometry in combination with cloning of the corresponding variable domain-encoding genes. Such technology in combination with determination of the affinity for the immunizing agent has in the past been used to decipher the extent of affinity maturation in the much more commonly occurring cells of the B cell lineage that encode isotypes other than IgE [16] . However, even when access to such human IgE-producing clones can be ensured in the future, many IgE responses pose a very specific problem in the context of analysis of affinity maturation. Many allergens have cross-reacting counterparts in other species or are even represented by a multitude of more or less similar isoallergens and isoforms within a given species [23] . In most cases it will likely be impossible to know the allergen form(s) that originally induced the response and that was/were the driver in the affinity maturation process that eventually resulted in the population of IgE-producing B cells observed in a given allergic individual. Consequently it will likely be very difficult to define with certainty the extent of affinity maturation that has occurred in vivo unless one is able to assess a response involving few cross-reacting allergens/allergen isoforms or a response focused on a conserved epitope. Until these conceptual matters have been resolved and given the inability of even a highly validated statistical methodology to detect positive selection in IgG-encoding antibody populations, we suggest that claims of the presence or lack of selection in IgE responses, and its relation to the mechanism of IgE-mediated disease, have to be treated with caution.
